The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the Type II diabetes mellitus patients: a case–control study

The use of lycopene as a complementary medicine for Type II diabetes mellitus (T2DM) is limited and controversial. This study evaluated the effect of lycopene intake on the changes of glycaemic status and antioxidant capacity among the T2DM patients.

File Type: 1943515
Categories: By Others, Lycopene
Tags: Metabolic Health

Continue reading

January 2026 – A New Year and Bright Road Ahead!

        A New Year and Bright Road Ahead! Dear Partners, I’m beginning my first full year leading Lycored feeling inspired by the significant milestones of 2025: Our...

December 2025 – Introducing Lumenato and Lycoderm to the European Union

Two of our powerhouse beauty from within solutions — both derived from tomatoes —made the European Food Safety Authority (EFSA) list of novel foods and are officially available for sale...

November 2025 Newsletter – Our most versatile solution 🤝 Your latest product formulation

Breaking news - One ingredient, many solutions! Our new VAS (versatile application solution) technology hit the market November 6th.

We're here for you

Interested in speaking directly with a member of our team?
Click below to get in touch.

Contact us